πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7976743

Gas-containing liposomes

The Board of Regents of the University of Texas System Β· Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7968115

Liposomal curcumin for treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7960133

Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase

The Board of Regents of the University of Texas System Β· Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7951356

Tissue factor compositions and kits for coagulation and tumor treatment

The Board of Regents of the University of Texas System Β· Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7951362

Compositions and methods of use of targeting peptides against placenta and adipose tissues

The Board of Regents of the University of Texas System Β· Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7943332

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using E

The Board of Regents of the University of Texas System Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7928062

Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

The Board of Regents of the University of Texas System Β· Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7927833

Composition and method for enhancing immune response

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7923014

Expression and purification of HIP/PAP and uses therefor

The Board of Regents of the University of Texas System Β· Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7923548

Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-n

The Board of Regents of the University of Texas System Β· Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7923010

Methods and materials for treating autoimmune diseases and conditions

The Board of Regents of the University of Texas System Β· Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7919579

Imaging and therapeutic targeting of prostate and bladder tissues

The Board of Regents of the University of Texas System Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7919613

RNAi modulation of SCAP and therapeutic uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7915245

Methods and compositions of trail-death receptor agonists/activators

The Board of Regents of the University of Texas System Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7914780

Aminopeptidase A (APA) targeting peptides for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7906628

Targeting proteins to deliver therapeutic or diagnostic reagents

The Board of Regents of the University of Texas System Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7906555

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbala

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7902166

Compositions comprising inhibitors of RNA binding proteins and methods of producing and us

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7897340

Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker

The Board of Regents of the University of Texas System Β· Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7893027

Treatment of ocular wounds and ulcers

The Board of Regents of the University of Oklahoma Β· Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7893033

Targeting proteins to deliver therapeutic or diagnostic reagents

The Board of Regents of the University of Texas System Β· Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7892567

Methods and compositions for immunization against chlamydial infection and disease

The Board of Regents of the University of Texas System Β· Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7887836

Compositions and methods for treating lymphoma

The Board of Regents of the University of Texas System Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7884211

Dimeric small molecule potentiators of apoptosis

The Board of Regents of the University of Texas System Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted